These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7257040)

  • 41. [Positive demonstration of bladder tumors by means of double contrast cystography].
    Ulshöfer B
    Helv Chir Acta; 1978 Jul; 45(3):317-22. PubMed ID: 701069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma.
    Nisman B; Barak V; Shapiro A; Golijanin D; Peretz T; Pode D
    Cancer; 2002 Jun; 94(11):2914-22. PubMed ID: 12115379
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic value of voided urine and bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract.
    Konety BR; Metro MJ; Melham MF; Salup RR
    Urol Int; 1999; 62(1):26-30. PubMed ID: 10436427
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urinary cytology in the detection of bladder tumours. Influence of concomitant urothelial atypia.
    Harving N; Petersen SE; Melsen F; Wolf H
    Scand J Urol Nephrol Suppl; 1989; 125():127-31. PubMed ID: 2633311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinicopathological study of urinary bladder tumors. Clinical evaluation of immunohistochemistry in urine cytology].
    Nagata Y; Kinoshita H; Kawamura N; Sasadaira S
    Hinyokika Kiyo; 1985 Nov; 31(11):1931-7. PubMed ID: 4091136
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic accuracy of DNA image cytometry and urinary cytology with cells from voided urine in the detection of bladder cancer.
    Planz B; Synek C; Robben J; Böcking A; Marberger M
    Urology; 2000 Nov; 56(5):782-6. PubMed ID: 11068301
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Further study of fibrinogen degradation products in bladder cancer detection.
    Wajsman Z; Williams PD; Greco J; Murphy GP
    Urology; 1978 Dec; 12(6):659-61. PubMed ID: 741544
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cytology in the detection and followup of urothelial tumors. Critical review of 500 cytologic investigations (authors transl)].
    Tostain J; Laurent JL; Pasteur X; Crochet J; Hugonnier G; Gilloz A
    J Urol (Paris); 1982; 88(2):91-6. PubMed ID: 7097029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multistage carcinogenesis in the urinary bladder.
    Cohen SM; Greenfield RE; Ellwein LB
    Environ Health Perspect; 1983 Mar; 49():209-15. PubMed ID: 6832093
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology.
    Kawauchi S; Sakai H; Ikemoto K; Eguchi S; Nakao M; Takihara H; Shimabukuro T; Furuya T; Oga A; Matsuyama H; Takahashi M; Sasaki K
    Hum Pathol; 2009 Dec; 40(12):1783-9. PubMed ID: 19733894
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A long-term study of reversible and progressive urinary bladder cancer lesions in rats fed N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Jacobs JB; Arai M; Cohen SM; Friedell GH
    Cancer Res; 1977 Aug; 37(8 Pt 2):2817-21. PubMed ID: 872108
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The value of the ImmunoCyt/uCyt+ test in the detection and follow-up of carcinoma in situ of the urinary bladder.
    Mian C; Lodde M; Comploj E; Palermo S; Mian M; Maier K; Pycha A
    Anticancer Res; 2005; 25(5):3641-4. PubMed ID: 16101194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urinary cytology and the Paris system for reporting urinary cytology: Implications for urological management.
    Gupta M; VandenBussche CJ; Bivalacqua TJ
    Cytopathology; 2018 Aug; 29(4):368-370. PubMed ID: 29575439
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urinary cytology for carcinoma in situ of the urinary bladder.
    Rosa B; Cazin M; Dalian G
    Acta Cytol; 1985; 29(2):117-24. PubMed ID: 3856981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Can the combination of bladder ultrasonography and urinary cytodiagnosis replace cystoscopy in the diagnosis and follow-up of tumors of the bladder?].
    Cariou G; Maaraoui N; Cortesse A
    Prog Urol; 1997 Feb; 7(1):51-5. PubMed ID: 9116739
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Preventive oncology in bladder cancer: determination of carcinogens in urine].
    Harzmann R; Gericke D; Bichler KH
    Helv Chir Acta; 1982 Aug; 49(3-4):409-14. PubMed ID: 7129910
    [No Abstract]   [Full Text] [Related]  

  • 57. Surveillance of stage O, grade I bladder cancer by cytology alone--is it acceptable?
    Morrison DA; Murphy WM; Ford KS; Soloway MS
    J Urol; 1984 Oct; 132(4):672-4. PubMed ID: 6471210
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Urinary cytology for carcinoma of the urinary bladder].
    Nagumo S; Matuda M; Kuroda M
    Rinsho Byori; 1992 Jul; 40(7):728-35. PubMed ID: 1507491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by postoperative urinary cytology.
    Badalament RA; Gay H; Cibas ES; Herr HW; Whitmore WF; Fair WR; Melamed MR
    J Urol; 1987 Oct; 138(4):763-5. PubMed ID: 3656528
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early lesions in experimental bladder cancer: experimental design and light microscopic findings.
    Cohen SM; Jacobs JB; Arai M; Johansson S; Friedell GH
    Cancer Res; 1976 Jul; 36(7 PT 2):2508-11. PubMed ID: 1277158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.